Khiron Financial Statements From 2010 to 2025

4KH Stock   0.02  0.00  0.00%   
Khiron Life financial statements provide useful quarterly and yearly information to potential Khiron Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Khiron Life financial statements helps investors assess Khiron Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Khiron Life's valuation are summarized below:
Khiron Life Sciences does not presently have any fundamental ratios for analysis.
Check Khiron Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Khiron Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . Khiron financial statements analysis is a perfect complement when working with Khiron Life Valuation or Volatility modules.
  
This module can also supplement various Khiron Life Technical models . Check out the analysis of Khiron Life Correlation against competitors.

Khiron Life Sciences Company EBITDA Analysis

Khiron Life's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Khiron Life EBITDA

    
  (32.03 M)  
Most of Khiron Life's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition
According to the company disclosure, Khiron Life Sciences reported earnings before interest,tax, depreciation and amortization of (32.03 Million). This is much lower than that of the sector and significantly lower than that of the EBITDA industry. The ebitda for all Germany stocks is notably higher than that of the company.

Khiron Life Sciences Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.
Khiron Life Sciences is rated third in current valuation category among its peers. It also is rated third in price to book category among its peers . The ratio of Current Valuation to Price To Book for Khiron Life Sciences is about  22,225,088 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Khiron Life's earnings, one of the primary drivers of an investment's value.

About Khiron Life Financial Statements

Khiron Life shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Khiron Life investors may analyze each financial statement separately, they are all interrelated. The changes in Khiron Life's assets and liabilities, for example, are also reflected in the revenues and expenses on on Khiron Life's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Khiron Stock Analysis

When running Khiron Life's price analysis, check to measure Khiron Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Khiron Life is operating at the current time. Most of Khiron Life's value examination focuses on studying past and present price action to predict the probability of Khiron Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Khiron Life's price. Additionally, you may evaluate how the addition of Khiron Life to your portfolios can decrease your overall portfolio volatility.